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Abstract A cysteine residue was introduced close to the active 
site of β-lactamase I by site-directed mutagenesis to replace 
tyrosine-105 and was subsequently modified with an electroactive 
SH-speciflc reagent, 7V-(2-ferrocene-ethyl)maleimide. The result-
ing modified enzyme became electroactive, showing good quasi-
reversible electrochemistry which was characteristic of the 
attached ferrocene moiety while retaining its specific enzymatic 
activity. In the presence of a suicide substrate, 6P-iodopenicil-
lanic acid, the redox potential shifted +20 mV suggesting that the 
label was sensitive to changes in the active site of the enzyme. 
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1. Introduction 
Over the past decade new methods have been developed 
that allow the electrochemical study of redox proteins and 
enzymes [1,2]. To extend the range of enzymes which could 
be analysed electrochemically we have investigated the possi-
bility of introducing redox-active groups into enzymes site-
specifically and thus open them up to study by electrochemical 
methods. To achieve the site-specific placement of a redox-
active group, one of the options is to introduce a thiol group 
into proteins by a single cysteine substitution at the desired 
position. Out of several nucleophilic groups found in proteins 
the sulphydryl group of cysteine is by far the most reactive. If 
the enzyme to be modified does not have other reactive cys-
teines, by replacing an amino acid residue by cysteine it be-
comes possible to introduce the electroactive label site-specif-
ically into the protein. 
Recently we reported the synthesis of a ferrocene-contain-
ing sulphydryl reagent: Af-(2-ferrocene-ethyl)maleimide (Fc-
Mi) [3]. This label has now been used in our attempt to devel-
op a general method to arrive at potentially new electrochem-
ical biosensors. 
As a model, we have studied the possibility of converting 
the redox-inactive enzyme β-lactamase I from Bacillus cereus 
into an electroactive enzyme. β-Lactamase I is a clinically 
important serine protease which lacks cysteine residues [4,5]. 
The 3-dimensional structure of this enzyme was provided by 
D. Stuart (personal communication). With the use of molecu-
lar graphics we have chosen possible sites that would allow 
the easy introduction of the electroactive label without clashes 
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thereby minimising disturbance to the protein's structure. In 
this way we hoped to achieve the aim of introducing an elec-
troactive group that would be sensitive to changes in the en-
vironment of the active site. Cysteine residues were introduced 
into strategically important positions and the mutant enzymes 
so obtained were further modified with Fc-Mi. 
Changes at the labelled enzyme's active site were studied by 
using inhibition of the modified β-lactamase I [6]. όβ-Iodope-
nicillanic acid (6β-ΙΡΑ) is a suicide substrate of β-lactamase I 
[7,8] which upon enzyme catalysis becomes irreversibly cap-
tured by the enzyme and so causing its inactivation. 
Herein we give details on the preparation and expression of 
three mutant β-lactamases and the conditions for their chemi-
cal modification with Fc-Mi. The electrochemical and kinetic 
behaviours of the wild-type enzyme and one of the success-
fully modified enzyme-mutant in the presence of a substrate/or 
an inhibitor are compared and discussed. 
2. Materials and methods 
2.1. Materials 
Chemicals and solvents used were reagent grade and used without 
further purification unless otherwise noted. Water for all solutions 
was purified using a Milli-Q water purification system (Millipore). 
Nitrocefin was a gift from Dr. J. Errington, Sir William Dunn School 
of Pathology Oxford, όβ-ΐοάορβηΐοΐΐΐβιιΐο acid was a gift from Pfizer 
Ltd., Kent. 
β-Lactamase single mutants, where either Tyr105, Ser129 or Trp210 
were replaced by cysteine, were constructed in the phagemid vector 
pKScatPl (obtained from T. Leung, Sir William Dunn School of 
Pathology Oxford) using the uracil template protocol [9] and ex-
pressed in Bacillus subtilis [10] with the bacteriophage vector 
pSG703. In this expression system the enzyme is secreted into the 
medium after heat shock and 6 h growth. The purification of the 
mutant enzymes was achieved by adsorption to, and elution from, 
Celite, followed by ion exchange chromatography on CM Sephadex 
G50 (Pharmacia) column using 50 mM Tris-HCl buffer (pH 7) with a 
gradient (final concn.: 1 M KC1). All buffers used were degassed and 
contained 10 mM DTT and 1 mM EDTA to prevent auotooxidation 
of the sulphydryl group of the cysteine. Fractions containing β-lac-
tamase activity were pooled, concentrated using Amicon 10 ultrafil-
tration membrane and desalted by exchanging the buffer into the 
initial low salt buffer. This protein solution was passed through a 
PD 10 (Pharmacia) column just before treating it with Fc-Mi. 
2.2. Methods 
Direct current (DC) cyclic voltammetry and differential pulse volt-
ammetry experiments were carried out at room temperature in a two 
compartment glass cell with a working volume of 0.5 ml. The working 
compartment accommodated the platinum gauze counter electrode in 
addition to the edged plane pyrrolytic graphite working electrode. A 
saturated calomel electrode (SCE) was used as a reference in a side-
arm which connected to the working compartment via a Luggin cap-
illary. All potentials are referred to the SCE. An AUTOLAB R 
potentiostat by Eco Chemie BV was used to record and control the 
potential of the working electrode. All measurements were made in 50 
mM Tris-HCl/200 mM KC1 buffer (pH 7.0). 
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2.3. Modification of enzymes with Fc-Mi 
Stock solutions: Fc-Mi (20 mM in ethanol); β-lactamase I (20 μΜ 
in 50 mM Tris-HCl buffer (pH 7.0). 
Two millilitres of protein solution and 24 μΐ of Fc-Mi (12-fold 
excess of label) were mixed and left to react at 20°C for 6 h in the 
dark. At the end the protein mixture was passed through a PD10 
(Pharmacia) column to remove excess of reagent, purified by FPLC, 
and used for electrochemical and enzyme activity measurements. 
2.4. Enzyme concentration's measurements 
Enzyme concentrations were determined spectrophotometrically, 
using a Hewlett Packard 8451 A Diode Array spectrophotometer. 
The concentration of β-lactamase mutants were determined at 280 
nm using a molar extinction of 231 mM -1 cm-1 [11]. 
2.5. fi-lactamase activity assay 
Nitrocefin, as a coloured substrate for penicillinase, was used as a 
qualitative test to detect β-lactamase activity during purification steps. 
Quantitative assays with this substrate at saturated substrate concen-
trations were also set up [12,13] to compare activities of the wild-type, 
mutant and ferrocene-modified β-lactamases. Substrate hydrolysis was 
monitored spectrophotometrically at 500 nm. 
2.6. Inactivation of fi-lactamase I and its Fc-labelled mutant Y105C 
with the suicide substrate 6$-IPA 
Stock solution of 6β-ΙΡΑ: 2.4 mM in distilled water. 
To a 10 μΜ enzyme solution in 50 mM sodium phosphate, 0.5 M 
NaCl buffer (pH 7) 6β-ΙΡΑ was added in 1-10-fold excess of inhibitor 
to enzyme concentrations. The mixture was incubated for 10 min at 
30°C and the suicide reaction was monitored by following the forma-
tion of dihydrothiazine at 326 nm (ε: 12 500 M_1 cm-1; [14]). The 
ratio of dihydrothiazine/enzyme concentrations were calculated and 
used as a measure for inhibition efficiency [7]. 
3. Results 
Freshly purified β-lactamase I mutants Y105C, S129C and 
W210C were treated in an identical fashion with Fc-Mi. How-
ever, after purification and iron content analysis, only one 
mutant proved to be modified with Fc-Mi. This was the 
Y105C mutant. The relative activities of the mutant enzymes 
and that of the modified one were determined and compared 
to the wild-type β-lactamase I. The activities of the mutant 
proteins relative to the wild-type were 95% for Y105C, 90% 
for S129C, 92% for W210C while the Fc-modified enzyme 
showed somewhat reduced activity (30% of the native). In 
all cases the margin of error was ± 10%. 
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Fig. 1. Cyclic voltammograms of the wild-type β-lactamase (a) and 
the ferrocene-modified Y105C mutant (b) were taken in 50 mM 
Tris-HCl buffer (pH 7). Enzyme concentrations were 10 μΜ in each 
case. Scan rate: 20 mV s-1. 
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Fig. 2. Differential pulse voltammograms of the ferrocene-labelled 
β-lactamase mutant (10 μΜ in 50 mM Tris-HCl buffer, pH 7) in 
the absence (a) and in the presence of 60 μΜ 6β-ΙΡΑ (b). Scan 
rate: 20 mV s_1. 
The efficiency of the suicide substrate was tested with the 
wild-type β-lactamase I and Fc-Mi modified β-lactamase mu-
tant Y105C. It was found that a 3-fold excess of 6β-ΙΡΑ 
completely inhibited enzymatic activity of the wild-type β-lac-
tamase I in 5 min while a 6-fold excess of the inhibitor was 
needed to inactivate the modified enzyme within the same 
time. 
The DC cyclic voltammogram of the unmodified and the 
Fc-Mi treated β-lactamase Y105C is shown in Fig. 1. While 
the unmodified enzyme remained electrochemically silent in 
the range of 0-500 mV (a), the ferrocene-modified β-lactamase 
Y105C shows redox activity, confirming the incorporation of 
the ferrocene label into the protein (b). Its DC cyclic voltam-
mogram is consistent with the electrochemically reversible be-
haviour of a ferrocene/ferricinium ion one-electron redox cou-
ple (E1/2 = 193 mV, AEP = 63 mV, ipa/v
1/2 = constant). 
Differential pulse voltammetry experiments were carried out 
with the ferrocene-labelled β-lactamase I in the absence (Fig. 
2a) and in the presence of 6β-ΙΡΑ (Fig. 2b). The redox po-
tential of the ferrocene-modified β-lactamase shifted from 193 
to 214 mV upon addition of its suicide substrate. Here an 
additional oxidation peak was obtained at 360 mV. 
4. Discussion 
The fact that out of the three mutants expressed, we could 
only introduce the ferrocene label into one mutant (Y105C), 
might imply that, in the other two cases, the chosen sites, 
where the cysteine residue was inserted, were not sufficiently 
close to the protein's surface to react with the reagent. The 
relatively low specific activity obtained for the modified en-
zyme is probably due to the fact that the site where the label 
was introduced is close to its active site entrance and so the 
bulky ferrocene molecule perturbs the free access of the sub-
strate into the catalytic pocket. This observation is consistent 
with the results obtained with the suicide substrate's efficiency 
test, where double amount of 6β-ΙΡΑ was needed to inhibit 
completely the ferrocene-modified enzyme activity, compared 
with the wild-type enzyme. 
DC cyclic voltammetry experiments with the wild-type and 
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the redox-labelled β-lactamase mutant Y105C (Fig. 1) demon-
strates that the Fc-Mi covalently reacted with its single cys-
teine residue providing the latter with quasi-reversible redox 
properties due to the attached ferrocene moiety. The selectiv-
ity of the label towards cysteine residues was earlier demon-
strated [3], and the fact that the other cysteine containing 
enzyme mutants (S129C and W210C) did not became electro-
active upon Fc-Mi reaction further suggests that the chosen 
sites were not readily available for chemical reaction. 
Differential pulse voltammetric studies revealed a funda-
mental shift in the redox potentials of the ferrocene-labelled 
β-lactamase Y105C mutant upon the addition of its suicide 
substrate: 6β-ΙΡΑ (Fig. 2a,b). The presence of the covalently 
captured substrate analogue in the enzyme's active site had a 
direct electronic effect on the ferrocene moiety by increasing 
its redox potential. This result indicates that the label used 
was placed successfully close to the enzyme's catalytic centre 
and in a position that became intimately sensitive to changes 
in the active site. The additional oxidation peak attained at 
360 mV in the presence of 6β-ΙΡΑ was due to the formation of 
a redox active species, dihydrothiazine, upon substrate turn-
over. 
The results presented in this paper not only demonstrate the 
feasibility of converting redox-inactive enzymes redox-active 
but most significantly, as the introduced electroactive label 
became sensitive to changes in the enzyme's active site, gives 
the potential to develop novel electrochemical biosensors 
based on the site-specifically placed ferrocene label. 
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